SRGRF yields 0.43% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 8
Combined, SRGRF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SRGRF + PFE for your $10,000?
Sunpower Group Ltd. provides environmental protection solutions in the People's Republic of China, the United States, Canada, India, Southeast Asia, the Middle East, Europe, South America, and Oceania. It operates through Manufacturing & Services and Green Investments segments. The company's Manufacturing & Services segment develops heat exchangers, pressure vessels, heat pipes, heat pipe exchangers, pipeline energy saving, and related environmental protection products. This segment also offers solutions for flare and flare gas recovery system, zero liquid discharge system, petrochemical engineering, energy saving system, desulphurization, and denitrification systems. Its Green Investments segment focuses on the investment, development, and operation of centralized heat, steam, and electricity generation plants. In addition, it offers design, consultancy, and technology services to the thermal power, construction materials, architecture, municipal engineering, and other industries. Further, the company provides design, consultation, and technology services; produces and sells foam glass products; and supplies heat and electricity to enterprises. It serves chemicals, textiles, textile printing and dyeing, food, paper-making, paints, pharmaceuticals, leather, wood processing, plastic recycling, fodder, chemical fertilizers, and rubber industries. Sunpower Group Ltd. was founded in 1997 and is headquartered in Nanjing, the People's Republic of China.
Full SRGRF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.